Will CPAP Reduce Length Of Respiratory Support In Premature Infants? (OLIVIA)
Offering Less Invasive Ventilation in Infants Born 28 to 32 Weeks Gestation: A Randomized Controlled Trial.
Sponsor: Child and Family Research Institute
Terminated
Decreasing recruitment
Other Prematurity trials with similar outcome
Listed as NCT00486395, this PHASE3 trial focuses on Prematurity and Respiratory Distress Syndrome, Newborn and remains terminated or withdrawn. Sponsored by Child and Family Research Institute, it has been updated 5 times since 2007, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Terminated PHASE3
First recorded
Sep 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Child and Family Research Institute
- Children's & Women's Health Centre of British Columbia
For direct contact, visit the study record on ClinicalTrials.gov .